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Molecular technology to identify relatedness 
between  Mycobacterium tuberculosis  complex iso-
lates, representative of possible tuberculosis (TB) 
transmission between individuals, continues to 
evolve. At the same time, tools to utilise this infor-
mation for public health action to improve TB control 
should also be implemented. Public Health England 
developed the Strain Typing Module (STM) as an inte-
gral part of the web-based surveillance system used in 
the United Kingdom following the roll-out of prospec-
tive 24 loci mycobacterial interspersed repetitive unit-
variable number tandem repeat (MIRU-VNTR) strain 
typing. The creation of such a system required data 
integration and linkage, bringing together laboratory 
results and patient notification information. The STM 
facilitated widespread access to patient strain typing 
and clustering results for the public health community 
working in TB control. In addition, the system provided 
a log of cluster review and investigation decision mak-
ing and results. Automated real-time data linkage 
between laboratory and notification data are essential 
to allow routine use of genotyping results in TB sur-
veillance and control. Outputs must be accessible by 
those working in TB control at a local level to have any 
impact in ongoing public health activity.
Introduction
Tuberculosis (TB) incidence in the United Kingdom (UK) 
increased during the early 2000s from 12.3 per 100,000 
in 2000 to 15.1 per 100,000 in 2005 [1]. Following this, 
recommendations for improvements in TB control were 
made in the Chief Medical Officer’s Action Plan for 
TB [2]. This included improved TB surveillance activ-
ity through the implementation of routine prospective 
molecular typing. In response, in 2010, the National 
TB Strain Typing Service (TB STS) was established by 
Public Health England [3] to prospectively identify and, 
where necessary, investigate 24 loci mycobacterial 
interspersed repetitive unit-variable number tandem 
repeat (MIRU-VNTR) strain typing clusters [4].
The routine, prospective and universal use of molecu-
lar characterisation techniques, such as MIRU-VNTR 
strain typing, have multiple benefits in clinical care 
and public health as previously described [5]. One of 
which is the role in identifying TB transmission, with 
an aim to interrupt it. This can, firstly, be achieved by 
confirming or refuting suspected transmission using 
MIRU-VNTR, secondly, by identifying MIRU-VNTR clus-
ters where there had previously been no suspicion of 
transmission.
To efficiently use MIRU-VNTR strain typing results for 
public health action in the UK, the data collected in 
routine TB notification and culture results in labora-
tory isolate records were linked. This was achieved 
within a custom-designed Strain Typing Module (STM) 
embedded in the current web-based national surveil-
lance system, the Enhanced Tuberculosis Surveillance 
System (ETS). The STM was therefore able to provide 
one central database and a user-friendly real-time view 
of all MIRU-VNTR clusters along with the associated 
patient information. These data sources combined are 
required to review clusters and investigate whether 
public health action was required, beyond routine con-
tact tracing [4].
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In this paper we describe the process of linking TB 
notification and laboratory isolate records and outline 
the structure and features of the STM. In addition, we 
describe its use in the systematic detection of clus-
ters, their review and recording the management of 
outbreaks and investigations in the UK. We hope that 
reflecting on our experience of integrating genotyp-
ing into TB surveillance for routine use will provide 
insights for other countries planning to make efficient 
use of molecular TB data. In addition, within the UK we 
can build upon our experience to develop an improved 
system for the roll-out of whole genome sequencing 
(WGS).
Methods
Dataflow and record linkage
A simple and easily maintained dataflow setup which 
utilises multiple data sources was essential to ensure 
that information was readily available and in a suitable 
format for users, in this instance public health profes-
sionals working in TB control.
In the UK, all  Mycobacterium  isolates cultured in 
local laboratories were sent to one of the reference 
laboratories for speciation, drug susceptibility testing 
(DST) and molecular typing (24 loci MIRU-VNTR 
strain typing between 2010 to 2016; strain typing 
in the UK is being gradually phased out starting 
from 2016 to be replaced with WGS). Mechanisms 
were developed to extract these results (for all cul-
ture-positive  Mycobacterium  isolates) along with 
patient identifiers from the  Mycobacterium  reference 
laboratory information management systems (LIMS) 
with output sent to Public Health England’s national TB 
Surveillance Unit.
At the time of implementing the TB STS, which pre-
scribed action to be taken based on the findings of 
strain typing data, there was no mechanism to easily 
incorporate strain typing results into the electronic 
surveillance system on a routine basis [6]. Therefore, 
to facilitate routine cluster review and investigation, 
designated cluster investigators extracted the relevant 
demographic, clinical and risk factor data from ETS for 
clustered cases based on MIRU-VNTR Microsoft Excel 
reports received from the reference laboratories. They 
Figure 1
Tuberculosis data flow and linkage for cluster review and investigation, United Kingdom, 2013–2016
Mycobacterium Reference 
Laboratories Laboratory 
Information Management 
System (LIMS)
Isolate record with species, 
DST and MIRU-VNTR results
Enhanced Tuberculosis 
Surveillance System 
laboratory data 
Enhanced Tuberculosis 
Surveillance System case 
notifications with laboratory 
results displayed
London Tuberculosis 
Register
Other enhanced 
surveillance activities 
including Mycobacterium 
bovis and drug-resistant TB
Strain Typing Module 
Cluster Reports
Clustering of 
MIRU-VNTR 
profiles
Matching 
algorithms
Case 
notification 
data
DST: drug susceptibility testing; MIRU-VNTR: mycobacterial interspersed repetitive unit-variable number tandem repeat; TB: tuberculosis.
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manually linked these data in a Microsoft Access data-
base. This resulted in significant manual manipulation 
of data, which was laborious and time-consuming and 
can lead to the introduction of mistakes. In order to 
streamline the process and reduce processing time, 
an automated process was set up to import laboratory 
results directly into ETS where they could be linked with 
patient data (Figure 1). Automated record linkage was 
implemented using an algorithm that matches patient 
identifiers from isolate records with those of notifica-
tions using two matching methods: (i) by automatically 
assigning the laboratory result to a notification through 
deterministic matching or (ii) by displaying the labora-
tory result as a possible match for a notification using 
probabilistic matching (Figure 2). 
Data manipulation and algorithms
The STM was integrated directly into ETS (Figure 1) as 
a module to display clusters of patients’ within specific 
geographies. To ensure the display in the STM was use-
ful for public health teams reviewing clusters, an algo-
rithm was developed to process the isolate data and 
return clusters with one summary result per patient’s 
TB episode. This process ensured that all isolates 
belonging to the same patient (identified by identical 
forename, surname and date of birth) and sampled 
within 365 days of each other were de-duplicated 
and merged together to create one record per patient 
(Figure 3).
A further algorithm was then implemented to compare 
these merged and de-duplicated isolates, representa-
tive of a patient’s TB episode, identifying patients with 
indistinguishable strain types which therefore com-
prised molecular clusters. The definition used for a 
cluster in the UK was two or more patients with indis-
tinguishable 24 loci strains, with at least one having a 
complete 24 loci MIRU VNTR profile; additional strain 
types in the cluster may each have one missing locus 
[4]. Each cluster was assigned a name within the sys-
tem, the nomenclature for naming clusters being a let-
ter which denotes the phylotype of the strain (A = East 
African Indian, B = Beijing, C = Central Asian, E = Euro-
American, F = Mycobacterium africanum, V = M. bovis, 
X = multiple global lineages, U = no global lineage) fol-
lowed by a four digit number assigned in sequential 
order (for example B1001, then B1002).
Results
Data collected in the system
Between 2010 and 2015, the ETS laboratory database 
held records for 42,148 isolates which the system de-
duplicated as representative of 28,741 TB patient epi-
sodes, of which 23,646 (82.3%) had a strain typing 
result. These individuals belonged to 2,701 different 
molecular clusters, which were displayed in cluster 
reports in the STM. In addition, 89 cases (either not cul-
ture-confirmed or not typed to 24 loci) were manually 
Figure 2
Algorithm to link tuberculosis laboratory and case data, United Kingdom, 2013–2016
Stages 1 and 2: Automatic match
Stage 1: Identical NHS number (unique national ID)
Matched
Notification 1223456789
Isolate 1223456789
Not matched, but considered for Stage 2
Notification
Isolate 1223456789
Never matched at any stage 
Notification 1223456789
Isolate 2223456789
Stage 2: Incomplete NHS numbers, identical forename, surname, date of birth and sex
Matched
Notification Joe Bloggs 01/01/1990 Male
Isolate Joe Bloggs 01/01/1990 Male
Not matched, but considered for Stage 3
Notification Jo   Bloggs 01/01/1990 Male
Isolate Joe Bloggs 01/01/1990 Male
Never matched at any stage
Notification Jess Bloggs 11/06/1960 Female
Isolate Joe  Bloggs 01/01/1990 Male
Stage 3: Suggested match for manual acceptance 
Fuzzy match on forename, surname, date of birth, sex and postcode
Considered for match
Notification Joe Bloggs 10/10/1990
Isolate Joe Bloggs 01/01/1990 Male
Never considered for match
Notification Harry Bloggs 10/10/1990 Male
Isolate Joe     Bloggs 01/01/1990 Male
ID: identification number; NHS: National Health Service.
For all stages (1–3) matches are only considered if the notification and specimen date are within 365 days of each other. This is to avoid 
matching isolates to the wrong episode of tuberculosis if a patient has multiple episodes.
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added to clusters in the STM based on epidemiological 
intelligence and information gathered through cluster 
investigation.
Between 2013 (when daily import of new laboratory 
results into ETS commenced) and 2015 (the last full cal-
endar year of strain typing use in the UK), the median 
time between specimen receipt in the reference labora-
tory and the MIRU-VNTR results being available to view 
in ETS was 2.3 months (70.9 days; interquartile range 
(IQR): 46.8–123.8).
Features and functions of the Strain Typing 
Module
The features and functions of the STM are outlined 
using our example of the fictitious patient Joe Bloggs 
and fictitious cluster B1363 (Figures 4 and 5).
Identifying new cases and clusters to review
During a routine local cluster review in the East of 
England region in August 2017, cluster B1363 was 
identified to contain a new case, Joe Bloggs, with five 
cases in total from the Peterborough area. Recent 
cases (specimen date within the last 3 months) were 
highlighted in yellow in cluster reports (Figure 4, Panel 
A) and clusters containing a recent case could be fil-
tered within the cluster report. Alternatively, the clus-
ter report could be downloaded into Microsoft Excel for 
import into statistical software packages, allowing ad 
hoc and more sophisticated analysis.
Isolates were assigned to a geographical area, such 
as the East of England, based on the local laboratory 
where the isolate originated. Cluster reports were avail-
able at a national, regional and local health protec-
tion team level. Users could access reports within the 
STM which showed only clusters and isolates/patients 
within their jurisdiction.
Demographic, clinical and risk factor information (as 
entered on ETS at time of notification) could be viewed 
in the STM for clustered cases where laboratory results 
had been matched to notifications (Figure 2). This facil-
itated the review of clustered cases in identifying risk 
factors for transmission and determining whether clus-
ter investigation was warranted. On review of B1363, it 
was identified that three of the cases have a history of 
homelessness (one being Joe Bloggs), four were born in 
the UK and four had pulmonary TB (Figure 4, Panel A). 
Based on these risk factors for potential cluster growth 
associated with a high-risk contextual setting, the clus-
ter investigator recommended that a cluster investiga-
tion should be launched and discussed this with the 
local health protection team, logging the investigation 
status and actions in the STM (Figure 4, Panel B).
The cluster investigator wanted to see if any other 
cases existed in the cluster nationally and therefore 
used the STM search functionality (Figure 5, Panel A). 
Two searches were available: search by MIRU-VNTR 
profile and search by cluster number. Each search pro-
vided a list of isolates with the strain type and/or clus-
ter number along with a geographical breakdown. The 
search for cluster B1363 revealed two additional cases 
in a neighbouring area, one of whom had occurred ear-
lier than any other case in the cluster.
Cluster investigation data collection tools
To aid cluster investigation, a standard questionnaire 
was used to obtain social network information includ-
ing details of the patients’ current and past locations 
of work, worship, socialising or imprisonment, stays at 
hostels, homeless shelters or hospitals, known expo-
sure to TB and travel abroad or household visitors from 
abroad [4] (Figure 5, Panel B). Patient-specific ques-
tions could also be entered. For B1363 cases, the clus-
ter investigator asked if the Peterborough cases had 
any links to the neighbouring area of Coventry where 
the other cases resided. The cluster investigator then 
submitted the questionnaire request in the system 
which automatically alerted the case manager to com-
plete. Alternatively, the questionnaire could be down-
loaded into Microsoft Word and sent by email, which 
was useful for case managers who were not users of 
the electronic notification system.
Once received, information collected in the question-
naires was compared by the cluster investigator to 
identify commonalities between patients and identify 
possible transmission settings. For fictitious cluster 
B1363, it was already known by the clinical team from 
standard contact tracing that Patient One and Patient 
Two were brothers. Both were homeless and had stayed 
in the Road One Hostel between January and May 2015, 
while Joe Bloggs had stayed in this same hostel on and 
off between November 2014 and April 2015. Before 
staying in the Road One Hostel, Patient One had been 
staying with friends in Coventry and regularly visited 
the Gold Goose Pub while there. This pub was also 
identified as a regular place of drinking for Other Area 
Figure 3
De-duplication and merging of tuberculosis laboratory 
results in the Strain Typing Module, United Kingdom, 
2013–2016
Isolates with: 
identical forename, surname and date of birth
+
identical DSTs, MIRU-VNTR, specimen type and 
specimen date 
Isolates with: 
identical forename, surname and date of birth
+
specimen date within 365 days 
+
DSTs and MIRU-VNTR on diﬀerent isolates
 
De-duplicated
Merge
DST: drug susceptibility testing; MIRU-VNTR: mycobacterial 
interspersed repetitive unit-variable number tandem repeat.
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Figure 4
Features and functionality of the Strain Typing Module, United Kingdom, 2013–2016
A. Cluster report
B. Cluster log
DOB: date of birth; F: female; HPU: Health Protection Unit; M: male; No.: number; UK: United Kingdom; VNTR: variable number tandem repeat.
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Patient A. These epidemiological links are logged in 
the STM (Figure 5, Panel C).
Patient Three was known to have a household con-
tact, her boyfriend, who previously had active TB and 
was her likely source of infection but had not been 
culture-confirmed and therefore did not have a MIRU-
VNTR result (thus not appearing in the cluster report). 
Such links between patients are routinely identified 
through contact tracing, with households first consid-
ered as settings for transmission before investigating 
and screening contacts from other contextual settings. 
From the cluster investigation it was also identified 
that Patient Three’s boyfriend was listed as a close 
contact of Patient One, but the boyfriend had failed 
to attend screening when invited. Given the likelihood 
that the boyfriend was part of the cluster, the cluster 
investigator manually added this epidemiologically 
linked patient to the cluster (Figure 4, Panel A).
None of the information obtained could link Other Area 
Patient B to the other cases in the cluster. This clus-
ter investigation identified three possible transmission 
settings, household(s) and two where awareness rais-
ing and screening, beyond screening of close contacts, 
could be targeted: the hostel in Peterborough and the 
pub in Coventry.
Discussion
Benefits of data integration
Bringing laboratory data into routine surveillance for 
public health provides effective and timely use of 
results. This includes using genetic relatedness infor-
mation to identify possible transmission events and 
settings for extended contact tracing [7,8], or to refute 
suspected transmission thereby preventing spending 
of unnecessary resources. It should be noted that the 
integration of laboratory and notification data has ben-
efits beyond cluster identification. Other surveillance 
activities such as routine drug resistance surveillance 
and zoonotic TB surveillance benefit from the real-time 
linkage of data, with DST and species results displayed 
in the notification module of ETS, as well as the STM 
for clusters. The record linkage also has an important 
role in monitoring under-notification by identifying how 
many culture-confirmed patients have not been noti-
fied and may not have been started on treatment.
The UK benefits from having a unique national health 
ID (NHS number), assigned at birth or on registration 
with primary care services and included in all elec-
tronic health records [9]. In recent years, the TB sur-
veillance and control community pushed for better 
routine use of the NHS number in TB reporting, both 
in the notification system and on all samples sent to 
local laboratories and in their referral to reference lab-
oratories. Between 2010 and 2015, 81% of TB notifica-
tions had an NHS number entered and 86% of isolate 
records imported into ETS from reference laboratory 
information management systems had an NHS number. 
This ensures that case and laboratory isolate records 
can be combined automatically at a national level 
[10]. It facilitates complete and accurate information 
compiling, with clustering results linked to epidemio-
logical data automatically in the STM for efficient and 
informed cluster review and investigation to be con-
ducted. Essential to all these activities was the ability 
to collate and store personal identifiers (names, dates 
of birth and national identification numbers) nation-
ally, for which a robust and comprehensive information 
governance structure was in place.
In addition, as the UK has clear data sharing agree-
ments in place, and the two TB data sources used here 
(notification and laboratory) were collected by one 
organisation, data linkage was possible. This may not 
be the case for organisations in other countries where 
further consideration of data protection issues may be 
necessary to conduct such data linkage.
Challenges and limitations
The ability to identify TB clusters relies on the availabil-
ity of culture confirmation and subsequent genotyping 
data being available. In the UK between 2010 and 2015, 
only 61% of TB cases were culture-confirmed, although 
this proportion was higher at 73% for pulmonary TB 
cases [1]. Furthermore, 16% of culture-confirmed cases 
were either not typed or received incomplete typing. 
Although the system allowed for manual addition of 
cases to clusters identified through traditional contact 
tracing and investigation (non-cultured/non-typed), 
we are unable to quantify the extent to which cluster 
investigation and the data provided by the system 
facilitated this identification.
Among cases identified as part of a cluster, data col-
lection benefited from having a structured cluster 
questionnaire to obtain information on regular places 
of social contact and interaction, with the ability to 
add patient-specific questions. This aids the identifi-
cation of epidemiological links between patients and 
transmission settings. Unfortunately, while the system 
allowed the recording of epidemiological links between 
cases, the use of this functionality was optional and 
was not always used by local teams investigating the 
clusters. In addition, the function to record transmis-
sion settings may have identified common settings 
to be followed up during investigation, but was not 
designed or completed well enough to enable analysis 
of these data nationally across all clusters.
The cluster questionnaire did not set out how case 
managers should interview their patients. The ques-
tions asked were of a personal nature and patients may 
feel these were intrusive; this was particularly true if 
the social network included drug dealing and use. 
Often the information received from cluster question-
naires was limited, but it was not known whether this 
was due to patients’ reluctance to provide information 
or if the questions were not posed in a way to facilitate 
the patients’ recall. Training and decisions about how 
7www.eurosurveillance.org
Figure 5
Features and functionality of the Strain Typing Module, United Kingdom, 2013–2016
A. Cluster search
B. Cluster questionnaire
C. Epi links
DOB: date of birth; F: female; HPU: Health Protection Unit; M: male.
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to phrase these questions to patients in order to get 
the most reliable information should be considered, 
as has been done by others [11]. However, there was 
also the awareness that retrospective data collection 
had its limitations. In our fictitious scenario, transmis-
sion settings were identified, but at least 2 years had 
passed since the transmission occurred. Consequently, 
any screening activities would have limited benefit, 
and this was often the case in real clusters and trans-
mission settings. Therefore, there is currently a desire 
to conduct prospective data collection on social net-
works at the time of notification as soon as two or more 
patients are molecularly linked, allowing earlier review 
of information. This should facilitate more timely and 
appropriate public health action once a cluster has 
been identified. Conversely, a small proportion of 
patients will be part of a cluster, and even fewer will be 
part of a cluster of public health importance; therefore, 
a large volume of unused data would need to be col-
lected and inputted by case managers.
Unfortunately, as the evaluation of the STS reported [6], 
the use of strain typing data and resulting public health 
action was limited by the fact that the STM was not 
available at the inception of strain typing. The evalua-
tion concluded that there was no evidence that cluster 
investigation was a cost-effective TB control method, 
recommending that routine systematic cluster investi-
gations should be terminated and instead initiated in 
response to local demand. This finding may have sub-
sequently affected the level of user engagement once 
the STM was fully implemented. Early consideration of 
software visualisation and logging (cluster review and 
investigation findings) systems remain an essential 
component of molecular technology roll-out.
Future opportunities
Genotyping results have a clear role in TB control, and 
the availability of these results and integration into 
routine surveillance activity are important. This has 
been exemplified previously by those working in TB 
surveillance and control in United States in their over-
view of the database created there to identify TB clus-
ters [12]. What remains essential is that these systems 
have a design led by public health.
As the UK moves to replace MIRU-VNTR with WGS, more 
complex data displays are necessary. This includes 
phylogenetic trees and matrix tables to quantify and 
visualise relatedness as sequencing data cannot be 
visualised as simply as strain typing data, i.e. as 
either the same 24 digit strain type or not. In the UK, 
the integration of such functionality into ETS was not 
possible given the age of the system (initially devel-
oped in 2008); therefore, a new system is required. A 
replacement surveillance system is planned but given 
the immediate roll-out of WGS, an interim solution to 
combine patient data and sequencing has to be devel-
oped. Interim and long-term solutions present the 
possibility of creating a system which builds on the 
successes of the STM in terms of data integration and 
linkage. This involves bringing together demographic, 
clinical, risk factor and social network information with 
molecular clustering results. In addition, functional-
ity to log cluster review and investigation action and 
findings including epidemiological links and/or trans-
mission settings is needed, as well as functionality to 
add non-culture confirmed, therefore not molecularly 
linked, cases. From use of the STM, we have identified 
additional features which could enhance and stream-
line cluster review and investigation processes, which 
are currently performed manually outside of the STM: 
firstly, the ability to create outputs such as timelines 
symbolising each time a patient is culture- or sputum-
positive and therefore at risk of transmitting, secondly, 
improved geographical assignment of isolates and/or 
patients based on postcodes rather than source labo-
ratories, as often the specimen referral pathways do 
not correlated with geographical location of patient 
residence or treatment; thirdly, the importance of local 
users having access to cluster results from across the 
country rather than only patients from their jurisdiction 
to allow efficient cross-boundary public health action.
While this all presents challenges, there are more imme-
diate benefits to be gained, such as the short time it 
takes to obtain sequencing results [13] compared with 
the time for strain typing, which we identified to be a 
median of more than 2 months from specimen date to 
receipt in the surveillance system. The timeliness of 
relatedness data along with prospective social net-
work data collection should have an impact on improv-
ing TB control in England. In addition, there are exciting 
opportunities for pan-European identification of clus-
ter and strain relatedness if sequencing data are held 
in a centralised system. A pilot project focusing on TB 
cases with multidrug resistance is underway [14].
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